Christopher D. Bahl

Massively parallel de novo protein design for targeted therapeutics

Aaron Chevalier, Daniel‐Adriano Silva, Derrick R. Hicks et al. · Nature · 2017 · 490 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +12

Accurate de novo design of hyperstable constrained peptides

Gaurav Bhardwaj, Vikram Khipple Mulligan, Christopher D. Bahl et al. · Nature · 2016 · 467 citations

Engineering, Computational Design, Drug Discovery +9

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Alyssa L. Kennedy, Kasiani C. Myers, James R. Bowman et al. · Nature Communications · 2021 · 177 citations · Full text

Medicine, Genetics, Hematology +17

Discovery and engineering of enhanced SUMO protease enzymes

Yue-Ting K. Lau, Vladimir Baytshtok, Tessa Howard et al. · Journal of Biological Chemistry · 2018 · 86 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

<i>Pseudomonas aeruginosa</i> sabotages the generation of host proresolving lipid mediators

Becca A. Flitter, Kelli L. Hvorecny, Emiko Ono et al. · Proceedings of the National Academy of Sciences · 2016 · 74 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17